Legend Biotech (LEGN) Construction in Progress (2019 - 2020)
Legend Biotech (LEGN) posted Construction in Progress of $33.6 million for Q4 2020, up 1082.74% on a QoQ basis from $2.8 million in Q4 2019, and up 1082.74% year-over-year from $2.8 million in Q1 2020.
Legend Biotech (LEGN) Construction in Progress (2019 - 2020) Analysis & Trends
Legend Biotech's Construction in Progress history runs 2 years deep, the most recent figure standing at $33.6 million for Q4 2020.
- Quarterly Construction in Progress rose 1082.74% year-over-year to $33.6 million in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $33.6 million (up 1082.74% YoY) and the FY2020 annual result came in at $33.6 million, up 1082.74% from the prior year.
- Construction in Progress was $33.6 million for Q4 2020 at Legend Biotech, up from $2.8 million in the prior quarter.
- Across five years, Construction in Progress topped out at $33.6 million in Q4 2020 and bottomed at $2.8 million in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 137.45 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Legend Biotech | 8.26 Bn | 7.36 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 33.64 Mn |
| Dec 31, 2019 | 2.84 Mn |